Yes , and this is closely related to the widely discussed phenomenon known as Ozempic Face. Ozempic Face describes the gaunt, hollow, or prematurely aged facial appearance that can follow rapid, significant weight loss on GLP-1 medications
This involves starting with a low-dose tablet thats gradually increased every month or so until you reach a target maintenance dose, similar to Wegovy injections
Understanding your genetic predispositions in peptide and glucose-control pathways may help provide context for your provider's risk-benefit analysis, supporting more informed decisions about whether compounded semaglutide aligns with your metabolic profile and safety needs
People whose BMI is 40.0 or greater are sometimes categorized as severely obese. The CDC has more information about BMI, its uses and how to calculate it
That is 4mg wasted
Separately, a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) by Godfrey et al., published in the Journal of the European Academy of Dermatology and Venereology (2025), found an elevated reporting odds ratio for alopecia with semaglutide of 2.46 (95% CI: 2.142.83)
.webp)
